MedPath

Study Of The Long Term Outcome Of Tuberculous Meningitis In Vietnamese Adults Treated With Adjunctive Dexamethasone

Completed
Conditions
Tuberculosis Meningitis
Interventions
Other: Observation
Registration Number
NCT01317654
Lead Sponsor
Oxford University Clinical Research Unit, Vietnam
Brief Summary

All patients who were alive at the end of the dexamethasone treatment trial conducted by Oxford University CLinical Research Unit from 2001-2005 (n=340) will be eligible to participate in this long-term follow-up study.

All eligible and consenting patients will undergo an assesment consisting of a simple questionnaire, a clinical examination and a blood test. Data collected will focus on survival, neurological disability and tuberculosis relapse. Data will be collected in individual case record forms and entered into a computer database.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
340
Inclusion Criteria

Patients were alive at the end of the dexamethasone study (n=340) will be eligible to participate in this long-term follow-up study Informed consent

Exclusion Criteria

Patients without informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Survivors of TBM trial 2001-2005Observation-
Primary Outcome Measures
NameTimeMethod
Survival5 years
Secondary Outcome Measures
NameTimeMethod
Neurological disability5 years
Tuberculosis relapse rate5 years
© Copyright 2025. All Rights Reserved by MedPath